Regenerative Medical Solutions, Inc.

Regenerative Medical Solutions (RMS) is an early stage company that is dedicated to helping find a cure for diabetes. RMS provides its pancreatic cells, ProgenMix, for pharmaceutical companies wishing to utilize these cells for drug discovery, efficacy and toxicity testing or as cells in progression toward a therapy. These cells provide an early indicator if drug candidates can be effective or hazardous and reduce the reliance on animal models, potentially saving millions of dollars in time and development costs. RMS's cells are derived from induced pluripotent stem cells, thus avoiding the ethical concerns of embryonic stem cells. RMS's intellectual property is derived from co-founder Dr. Jon Odorico's extensive work at the University of Wisconsin over the past decade.